About Biocomposites
Biocomposites is a Healthcare company based in Keele (United Kingdom) founded in 1999 by John Joseph Cooper, John Stephen Bratt, and Russell David Waters. Synthetic calcium composites are developed for bone repair and regeneration. Biocomposites has completed 1 acquisition, including ARTOSS. Biocomposites was last valued at $35.14 million in March 2017. Its website biocomposites.com draws about 15 thousand monthly visits. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is BIOCOMPOSITES (UK) LIMITED.
Company details
Developer of synthetic calcium composite products for bone repair and regeneration. The products include STIMULAN an absorbable calcium sulfate designed to be placed directly at the site of infection in bone and soft tissues. genex ia a synthetic bone graft substitute aimed at supporting natural bone healing, Biosteon is an osteoconductive calcium phosphate composite, AllogranR Bilok used in trauma, spine, and sports injury applications, and NanoBone SBX PuttyQD is a nanostructured hydroxyapatite grafts cleared for interbody spinal fusion.
- Headquarters Keele, United Kingdom
- Founders John Joseph Cooper, John Stephen Bratt, Russell David Waters
- Stage Minicorn
- SectorsHealthcare
- Phone•••• ••••
- Website biocomposites.com
- Social LinkedIn X Instagram
- Legal Name Biocomposites (Uk) Limited
- Date of Incorporation 06 Oct, 1999
- Jurisdiction NEWCASTLE, STAFFS
- Annual Revenue$53.36 M (USD)40as on Dec 31, 2016
- Net Profit$26.49 M (USD)as on Dec 31, 2017
- InvestorsNovo Holdings
& 1 more
- Investments & Acquisitions
Funding Insights of Biocomposites
- Total Rounds 2
- First Round $1.8M
(Mar 2017)
- Investors Count 2
All 2 funding rounds of Biocomposites with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | Unspecified | – | – | ||
| Mar 2017 | $1.8M | Unspecified | $35.14M | TA | – |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2017 | $35.14M | •••••••• |
Last known valuation $35.14M (Mar 2017). 2 investors in total: 2 institutional.
Investors in Biocomposites
Biocomposites has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Novo Holdings and TA Associates.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity and venture capital fund focused on the healthcare sector | novoholdings.dk | Hellerup, Denmark | ||
Multiple sectors are invested in by private equity firm TA. | ta.com | Boston, United States |
Investor details for Biocomposites
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biocomposites
60 people are tracked at Biocomposites (17 in leadership, 43 in team).
| Name | Role | Group |
|---|---|---|
John Joseph Cooper | Co-Founder | Leadership |
John Stephen Bratt | Co-Founder | Leadership |
Russell David Waters | Co-Founder | Leadership |
Courtney Nason | Director Of Finance | Leadership |
Clive Hon | Director Of Sales - Trauma / Foot & Ankle | Leadership |
Michael Harris | CEO | Leadership |
Bill Wengert | Regional Sales Director | Leadership |
Michelle Lewis | Human Resources Director | Leadership |
Phillip Laycock | Product Management Director | Leadership |
Hamish White | Chief Marketing Officer | Leadership |
Simon Greenhalgh | Group Chief Financial Officer | Leadership |
Frank Herrington | East Area Vice President | Leadership |
Davina Lawrence | National Sales Director | Leadership |
Dana Gergely | Director Of Marketing, Americas | Leadership |
Bill Spotti | Vice President US Sales | Leadership |
Stephany Karst | Regional Sales Director | Leadership |
Tim Beitzell | Director Of Sales - Spine | Leadership |
Yarko Horvath | National Sales Manager - Canada | Team |
Mark Sim | MDM - Spine | Team |
Bryan Smith | Field Sales Trainer | Team |
40 more people are available in the full profile.
Complete people profiles for Biocomposites
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocomposites
Biocomposites has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ARTOSS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Orthopedic and dental devices are distributed by ARTOSS. | artoss.com | Rostock, Germany | 2003 | Jun 2023 | •••• |
Complete acquisition details for Biocomposites
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Biocomposites
5 dated milestones of Biocomposites across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Biocomposites is founded.
- Funding First funding round of $1.8M.
- Milestone Reaches Minicorn status.
- Acquisition Acquires ARTOSS.
- Funding Latest funding round, Unspecified,.
Web traffic of Biocomposites
The website of Biocomposites (biocomposites.com) receives about 15.3K visits a month.
- Monthly visits15.3K
▲ 25.6% vs previous month
Websites whose visitors overlap most with Biocomposites. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
purchasing.uk-plc.net | purchasing.uk-plc.net | 100% | – | ||
orthopaediclist.com | orthopaediclist.com | 100% | #5,308,725 | – | |
| medicregister.com | 100% | #8,455,269 | View details | ||
healio.com | healio.com | 80% | #72,463 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biocomposites
Complete news archive for Biocomposites
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocomposites
Biocomposites was founded in 1999 and raised its 1st funding round 18 years after it was founded.
Biocomposites is headquartered in Keele, United Kingdom. It is registered at Keele, England, United Kingdom.
Annual revenue of Biocomposites is $53.36M as on Dec 31, 2016.
Developer of synthetic calcium composite products for bone repair and regeneration. The products include STIMULAN an absorbable calcium sulfate designed to be placed directly at the site of infection in bone and soft tissues. genex ia a synthetic bone graft substitute aimed at supporting natural bone healing, Biosteon is an osteoconductive calcium phosphate composite, AllogranR Bilok used in trauma, spine, and sports injury applications, and NanoBone SBX PuttyQD is a nanostructured hydroxyapatite grafts cleared for interbody spinal fusion.
Biocomposites has made 1 acquisition, including ARTOSS.
Biocomposites has 2 investors. Key investors include Novo Holdings, and TA Associates.
The valuation of Biocomposites is $35.14M as of Mar 2017.
Biocomposites operates through Biocomposites (Uk) Limited.